➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Moodys
Medtronic
Merck
Dow

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Bifeprunox

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Bifeprunox?

Bifeprunox is an investigational drug.

There have been 20 clinical trials for Bifeprunox. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2005.

The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Bipolar Disorder. The leading clinical trial sponsors are Solvay Pharmaceuticals, Wyeth is now a wholly owned subsidiary of Pfizer, and H. Lundbeck A/S.

Recent Clinical Trials for Bifeprunox
TitleSponsorPhase
Efficacy of Bifeprunox in Patients With SchizophreniaH. Lundbeck A/SPhase 3
Efficacy of Bifeprunox in Patients With SchizophreniaH. Lundbeck A/SPhase 3
Study Evaluating the Tolerability of Bifeprunox in Healthy SubjectsWyeth is now a wholly owned subsidiary of PfizerPhase 1

See all Bifeprunox clinical trials

Clinical Trial Summary for Bifeprunox

Top disease conditions for Bifeprunox
Top clinical trial sponsors for Bifeprunox

See all Bifeprunox clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Moodys
Medtronic
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.